Zimmer Biomet Holdings (ZBH) Revenue — Quarter Ended Dec 31, 2025
Revenue rose compared to both the prior quarter and the same quarter a year ago. The filing noted higher net sales in its operating cash flow discussion, while also referencing costs from acquisitions and tariffs.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue rose compared to both the prior quarter and the same quarter a year ago. The filing noted higher net sales in its operating cash flow discussion, while also referencing costs from acquisitions and tariffs.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.2B
Revenue reported for this quarter.
Quarter-over-quarter
+12.1%
Change from the immediately preceding quarter.
Year-over-year
+10.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$8.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $1.9B | +1.1% |
| Jun 30, 2025 | $2.1B | +7.0% |
| Sep 30, 2025 | $2B | +9.7% |
| Dec 31, 2025 | $2.2B | +10.9% |
Revenue performance
The filing reported higher net sales for the quarter. It also cited costs related to recent acquisitions and U.S. tariffs.
Quarterly comparison
Sequentially, revenue increased from the immediately preceding quarter. On a year-over-year basis, revenue was also higher than the same quarter one year earlier.
What to watch
The filing's discussion of acquisition and tariff costs may indicate factors to monitor in future quarters.